Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Purine synthesis pathway enzymes are a group of enzymes responsible for the biosynthesis of purine nucleotides, which are essential building blocks for DNA, RNA, and energy-carrying molecules like ATP and GTP. The pathway consists of two main routes: the *de novo* pathway, which constructs purines from small precursor molecules, and the salvage pathway, which recycles purine bases and nucleosides from cellular turnover. Key enzymes include PRPP synthetase, Glutamine PRPP amidotransferase (GPAT), GART, PAICS, ATIC, HPRT, and APRT. These enzymes are involved in *de novo* synthesis and salvage pathways. Purines synthesized are vital for nucleic acid production, cellular signaling, and energy transfer. Disruption in these pathways can lead to metabolic disorders or contribute to diseases such as cancer due to altered nucleotide pools affecting cell proliferation rates.
Varies depending on the specific enzyme; examples include inhibition of enzymatic activity, disruption of multienzyme complex formation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Purine Synthesis Pathway Enzyme (None).